New Gene Therapy for Certain Bladder Cancers

The First Gene Therapy for Bladder Cancer

The FDA approved the adenovirus-based gene therapy nadofaragene firadenovec for the treatment of localized bladder cancer. The U.S. Food and Drug Administration ...

New Gene Therapy for Certain Bladder Cancers - JAMA Network

The first gene therapy for treating high-risk bladder cancer that has not invaded muscle recently won FDA approval.

New gene therapy treatment to fight bladder cancer - VA News

Jennifer Taylor, urologic oncologist at Houston VA and an associate professor of urology at Baylor College of Medicine, Adstiladrin is a ...

UC San Diego Health Offers Novel Gene Therapy for Bladder Cancer

UC San Diego Health is the first health system in San Diego County to offer a new bladder-saving gene therapy to treat localized bladder cancer.

New Gene Therapy for Certain Bladder Cancers - PubMed

New Gene Therapy for Certain Bladder Cancers.

First Bladder Cancer Patient Dosed with Commercially Available ...

ADSTILADRIN® (nadofaragene firadenovec-vncg) is the first and only FDA-approved intravesical gene therapy for the treatment of adult patients ...

Suburban First to Offer New Gene Therapy Treatment for Bladder ...

Astiladrin is the first and only FDA-approved gene therapy delivered directly into the bladder for non–muscle-invasive bladder cancer (NMIBC).

Interferon gene therapy with nadofaragene firadenovec for bladder ...

Bladder cancer is a prevalent malignancy with limited therapeutic options, particularly for patients who are unresponsive to Bacillus ...

FDA Approves First Gene Therapy for Bladder Cancer | ASGCT

Adstiladrin is the first FDA-approved gene therapy for bladder cancer. It's indicated for people with high-risk superficial bladder cancer unresponsive to ...

Adstiladrin (Nadofaragene Firadenovec-vncg): The First Intravesical ...

Eligible patients will now have access to the first FDA-approved intravesical gene therapy for non-muscle invasive bladder cancer (NMIBC) at Fox Chase Cancer ...

Advances in Bladder Cancer Research - NCI

Gene Therapy. In 2022, the FDA approved a type of gene therapy called nadofaragene firadenovec-vncg (Adstiladrin) for some adults with a certain ...

FDA approves first adenoviral vector-based gene therapy for high ...

FDA approves first adenoviral vector-based gene therapy for high-risk Bacillus Calmette-Guérin unresponsive non-muscle invasive bladder ...

Bladder Cancer Treatment Advances: What's the Latest?

Bladder cancer treatment is advancing, with several approved immunotherapy options, an approved gene therapy, and an approach to cell therapy planned for ...

Ferring begins bladder cancer gene therapy rollout through focused ...

After securing approval at the end of last year for a potential alternative to bladder removal in certain bladder cancer patients, ...

Gene Therapy for NMIBC: A New Era of Treatment - Colin Dinney

Gene Therapy for NMIBC, adstiladrin Gene Therapy for BCG Unresponsive non-muscle invasive bladder cancer, Phase 3 Trial of Ad-interferon ...

First gene therapy for bladder cancer comes to Philadelphia - 6ABC

First gene therapy for bladder cancer comes to PhiladelphiaA new treatment has come to Philadelphia to help more bladder cancer patients ...

Early Experience Using Intravesical Gene Therapy for NMIBC

For more than 30 years, there has been little treatment advancement for NMIBC patients. Fortunately, a new development in the treatment of NMIBC ...

Intravesical Therapy for Bladder Cancer | American Cancer Society

This treatment is made up of a virus that contains the gene to make interferon alfa-2b, an important immune system protein. When the virus is ...

New Gene Therapy for Bladder Cancer - CancerConnect

A new FDA-approved gene therapy offers an alternative to complete bladder removal for patients with treatment-resistant non-muscle invasive ...

Webinar: Expanding Treatment Options for Non-muscle Invasive ...

For those whose tumors do not respond to BCG, a newly approved gene therapy may provide a valuable treatment for BCG unresponsive NMIBC.